Skip to main content
ACT logo

ACT · Enact Holdings, Inc.

Track ACT — free
$45.39 -0.44 (-0.96%) At close · Nov 13
Market Cap
$6.10B
Shares
134.44M
Volume · Nov 13 337.89K Avg daily vol (3M) 408.95K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$45.39 Open$46.06 Day$45.15–46.34 52W close$36.90–50.07 Avg vol 30d417K Short int3.0M · 2.2% of shares · 6.2d Short vol87% Last earningsNov 5, 2026 DataSep 2021–Nov 2026 Filing10-Q · Nov 5

Up next

Feb 3, 2027 Est · unconfirmed · in 11 wks

Latest documents

2026
Nov 5
Earnings call
Strong third-quarter results support higher capital return guidance

Enact Holdings, Inc. reported third-quarter adjusted operating income of $164 million, or $1.19 per diluted share, and new insurance written of $14 billion. The company raised 2026 capital return guidance to approximately $600 million, citing strong business performance.

4 source passages
Welcome to Enact's third quarter earnings call. Adjusted operating income was $164 million or $1.19 per diluted share compared to $1.12 per diluted share in the same period last year and $1.26 per diluted share in the second quarter of 2026. New insurance written was $14 billion in the quarter, down 7% sequentially as higher mortgage rates reduced refinance activity and flat year-over-year. As Rohit mentioned earlier, we are increasing our 2026 total capital return guidance to approximately $600 million, reflecting our continued strong business results and confidence in our business. Open the document at this passage
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Nine-month net income rises to $501,519 thousand

Enact reported nine-month net income of $501,519 thousand, up from $497,083 thousand, as new insurance written reached $42,091 million. Third-quarter new insurance written was $14,106 million, while the delinquency rate rose to 2.79% from 2.45%.

Revenue $312.85M ▲ 0.4% Net income $158.91M ▼ 2.8% Diluted EPS $1.15 ▲ 4.5%
Read from the MD&A section
5 source passages
In support, Enact has entered into an agreement with Genworth Holdings, Inc. to repurchase its Enact shares as part of the program to maintain Genworth’s current ownership interest in Enact. | Net income | 501,519 | | 497,083 | | 4,436 | 1 | % | | New insurance written | $42,091 | $37,120 | | New insurance written | $14,106 | $14,048 | | Delinquency rate | 2.79% | 2.45% | Open the document at this passage
Nov 4
Current report 8-K
Quarterly dividend $0.24; capital return outlook raised

Enact reported third-quarter net income of $159 million, or $1.15 per diluted share, declared a $0.24 quarterly dividend, and increased 2026 capital return guidance to approximately $600 million.

Financial results Read from the first part of this long document
3 source passages
Net income was $159 million, or $1.15 per diluted share, compared with $175 million, or $1.25 per diluted share, for the second quarter of 2026 and $163 million, or $1.10 per diluted share, for the third quarter of 2025. Today we announced the Company’s Board of Directors declared a $0.24 per common share, payable on December 17, 2026, to shareholders of record on November 25, 2026. We now anticipate a total 2026 capital return of approximately $600 million reflecting our continued strong financial position and confidence in our business; the final amount and form of capital returned to shareholders will depend on business performance, market conditions, and regulatory approval Open the document at this passage
Oct 30
Current report 8-K Events of Oct 29
Thomas J. McInerney resigns from board December 31, 2026

Enact Holdings, Inc. announced Thomas J. McInerney intends to resign from its Board effective December 31, 2026. His decision was not due to any dispute or disagreement with the company or its operations, policies or practices.

Director or officer change, or executive pay
2 source passages
On October 29, 2026, Thomas J. McInerney advised Enact Holdings, Inc. (the “Company”) and the Company’s Board of Directors (the “Board”) of his intention to resign from the Board effective December 31, 2026. Mr. McInerney’s decision to resign was not the result of any dispute or disagreement with the Company or any matter relating to the Company’s operations, policies or practices. Open the document at this passage
Aug 6
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $317.31M ▲ 4.1% Diluted EPS $1.25 ▲ 12.6%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.25B
Trailing 12 months
Net income (TTM)
$678.68M
Trailing 12 months
Revenue growth YoY
+0.4%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
9.4
Trailing earnings · reciprocal yield 10.6%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$195.91M
Latest balance sheet
Dividend yield
2.0%
Trailing 12 months
Shares change YoY
-6.8%
Year over year · fewer shares
Price change (1Y)
+20.7%
Trailing year
Short interest
2.2%
Latest settlement · 6.2 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 6, 2026
Q2 FY26

TL;DR. Enact reported 2Q26 adjusted operating income of $177M ($1.26/share) on $15B of NIW (+15% YoY) with strong credit, and raised 2026 total capital return guidance to $550-600M from $500M.

Bullish
  • + Raised 2026 total capital return guidance to $550-600M from prior $500M
  • + New insurance written grew 15% YoY to $15B with 87% purchase mix
  • + Loss ratio improved to 14% with $37M reserve release from favorable cures
Bearish
  • − Management expects delinquency rate to rise in 2H26 from newer vintages with less embedded HPA
  • − Base premium rate declined 0.3 bps sequentially to 39.1 bps with slight downward tilt for 2026
  • − Persistency declined 2 points YoY to 80% as mortgage rates remained elevated
  • − PMIERs sufficiency ratio declined to 161% from 162% sequentially and 165% YoY

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very Low
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +2%
above
Price vs 50-day avg −4%
below
RSI (14) 40
neutral
MACD trend Negative
52-week position 64%
mid-range
Momentum
relative strength
Very Strong
1-month return −2%
trailing
6-month return +6%
trailing
YTD return +15%
this year
Relative strength +5%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $47 › 200d $45 — 50d above 200d
Institutional flow Distributing
221 of 250 funds reported for Sep 30 · net -109.3K sh shares · +26 new
Insider flow Distributing
Net -$991.7K over 90 days · 100% sells
Short interest Falling
2.23% of shares out · ▼ -1.3% MoM · 6.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
250 holders — near 3-yr high, broad support
Squeeze score 55
elevated · 0–100
Fundamentals
Strong
Revenue growth +3%
Y/Y
EPS growth +3%
Y/Y
Valuation P/E 9.4
in line
Buyback $257.0M
remaining
Balance sheet $162.0M
net debt
Quant / Vol
risk profile
Very Low
Volatility 23%
annualized · 1-yr
Max drawdown −14%
past year
ATR 2.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 6, 2026
Total capital return · 2026 Maintained $550M – $600M
Aug 5, 2026 $550M – $600M changed to Aug 6, 2026 $550M – $600M
Operating expenses, excluding reorganization costs · 2026 Non-GAAP $205M – $210M
Previous outlook earlier release · from the Earnings Call filed May 6, 2026

Still-open targets the latest release did not restate under the same label.

Operating expenses · full year 2026 $215M – $220M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+2% Bullish
Price vs 50-day avg
−4% Neutral
RSI (14)
40 Neutral
MACD trend
Negative Bearish
52-week position
64% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $47 › 200d $45 — 50d above 200d
Institutional flow Distributing
221 of 250 funds reported for Sep 30 · net -109.3K sh shares · +26 new
Insider flow Distributing
Net -$991.7K over 90 days · 100% sells
Short interest Falling
2.23% of shares out · ▼ -1.3% MoM · 6.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
250 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $37 Now $45 · 64% Range high $50
vs 200-day avg +2% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Current period primary delinquencies 12,299 the second quarter of 2026 filing —
Delinquent loans (count) 24,330 the three months ended June 30, 2026 filing —
Net earned premium rate 0.34% the three months ended June 30, 2026 filing —
Primary policies in-force (count) 940,648 the three months ended June 30, 2026 filing —
Primary risk in-force 71.62B the three months ended June 30, 2026 filing —
Reserve release $37M the second quarter of 2026 filing —
Adjusted Operating Income non-GAAP 177.37M 2Q26 —
GAAP → non-GAAP reconciliation
GAAP NET INCOME 174.84M
+2.23M Net investment (gains) losses
+971K Costs associated with reorganization
-673K Taxes on adjustments
= Adjusted Operating Income 177.37M
Adjusted Operating Return on Equity non-GAAP 13.2% 2Q26 —
Expense Ratio 21% 2Q26 —
Loss Ratio 14% 2Q26 —
NIW ($B) 15B 2Q26 —
Primary IIF ($B) 274B 2Q26 —
Primary Persistency Rate 80% 2Q26 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Insurance - Specialty — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ACT
Enact Holdings, Inc.
this stock
$6.10B +14.5% +2.8% 9.4 2.2%
FNF
Fidelity National Financial, Inc.
$11.64B -20.5% +5.6% 11.1 4.5%
AXS
Axis Capital Holdings Ltd
$7.80B +1.5% +10.2% 8.3 3.0%
FAF
First American Financial Corp
$6.62B +5.6% +21.6% 9.2 5.9%
ESNT
Essent Group Ltd.
$5.68B -0.7% +1.5% 8.8 4.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
260
% held
22.0%
Reported
221 of 250
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
287
View
Short & Settlement
Short Interest Falling
Shares short
3.0M
Days to cover
6.2d
Change
-38.8K sh
View
Short Volume
Short vol %
87%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
3
Value
$137
As of
Oct 8, 2026
View
Off-Exchange
Off-exchange %
28.4%
Week of
Oct 5, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$991.7K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.2B
Net income (FY)
$674.2M
EPS diluted
$4.52
View
Buybacks
Authorized
$500.0M
Remaining
$257.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 5, 2026
This year
13

Enact reported nine-month net income of $501,519 thousand, up from $497,083 thousand, as new insurance written reached $42,091 million. Third-quarter new insurance written was $14,106 million, while the delinquency rate rose to 2.79% from 2.45%.

View
Proposed Sales
Value
$991.7K
Shares
20.0K
Filed
Aug 17, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
Enact to Host Third Quarter 2026…
Published
Oct 8, 2026
View

Performance

5D 20D 120D MTD YTD
ACT -2.2% -1.9% +5.8% -3.8% +14.5%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -4.8% -0.8% +5.3% -3.6% +3.9%

Capital returns

Latest dividend
$0.24 / share · ex Aug 20, 2026
Declared · upcoming
$0.24 / share · ex Nov 25, 2026
Raised 14.3%
Paid (TTM)
$0.90 / share · 4 payouts
Dividend yield (TTM, derived)
1.98%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$500.00M
Spent (derived)
$243.00M
Remaining
$257.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1823529 CUSIP 29249E109 13F (30d) 213 filings 188 filers Visit website Investor relations